Technical Articles
KRAS G13D
Application of KRAS G13D & VCB Binding Kit in Targeted Therapy
The KRAS gene is one of the most frequently mutated oncogenes in human cancers, appearing at high frequencies in pancreatic, colorectal, and lung cancers. As a central regulator of cellular signaling pathways, the KRAS protein functions like a molecular switch to control cell division and quiescence.
View details
- Cancer
- KRAS gene
- KRAS G13D
- Mutant oncogene
Application of Human KRAS G13D & VCB Binding Kit in KRAS-Targeted Therapy Research
The KRAS gene is one of the most frequently mutated oncogenes in human cancers, occurring in approximately 10-25% of non-small cell lung cancer cases and is closely associated with poor prognosis.
View details
- Cancer
- KRAS G13D
- Mutant oncogene
- Non-small cell lung cancer
- 1













